These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 8645244)
1. Identification of three separate binding sites on SHK toxin, a potent inhibitor of voltage-dependent potassium channels in human T-lymphocytes and rat brain. Pennington MW; Mahnir VM; Krafte DS; Zaydenberg I; Byrnes ME; Khaytin I; Crowley K; Kem WR Biochem Biophys Res Commun; 1996 Feb; 219(3):696-701. PubMed ID: 8645244 [TBL] [Abstract][Full Text] [Related]
2. Synthetic ShK-like Peptide from the Jellyfish Kim YJ; Jo Y; Lee SE; Kim J; Choi JP; Lee N; Won H; Woo DH; Yum S Mar Drugs; 2024 May; 22(5):. PubMed ID: 38786608 [TBL] [Abstract][Full Text] [Related]
4. Native chemical ligation at Asx-Cys, Glx-Cys: chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. Dang B; Kubota T; Mandal K; Bezanilla F; Kent SB J Am Chem Soc; 2013 Aug; 135(32):11911-9. PubMed ID: 23919482 [TBL] [Abstract][Full Text] [Related]
5. Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver. Wang Y; Hurley A; De Giorgi M; Tanner MR; Hu RC; Pennington MW; Lagor WR; Beeton C PLoS One; 2023; 18(4):e0283996. PubMed ID: 37040361 [TBL] [Abstract][Full Text] [Related]
6. Neurotoxins and pore forming toxins in sea anemones: Potential candidates for new drug development. Wang ZL; Zhang SY; Hao SL; Yang WX Histol Histopathol; 2023 Jan; 38(1):9-28. PubMed ID: 35880756 [TBL] [Abstract][Full Text] [Related]
7. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo. Smallwood TB; Navarro S; Cristofori-Armstrong B; Watkins TS; Tungatt K; Ryan RYM; Haigh OL; Lutzky VP; Mulvenna JP; Rosengren KJ; Loukas A; Miles JJ; Clark RJ J Biol Chem; 2021 Jul; 297(1):100834. PubMed ID: 34051231 [TBL] [Abstract][Full Text] [Related]
8. Marine Toxins Targeting Kv1 Channels: Pharmacological Tools and Therapeutic Scaffolds. Finol-Urdaneta RK; Belovanovic A; Micic-Vicovac M; Kinsella GK; McArthur JR; Al-Sabi A Mar Drugs; 2020 Mar; 18(3):. PubMed ID: 32245015 [TBL] [Abstract][Full Text] [Related]
9. Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond. Wang X; Li G; Guo J; Zhang Z; Zhang S; Zhu Y; Cheng J; Yu L; Ji Y; Tao J Front Neurosci; 2019; 13():1393. PubMed ID: 31992966 [TBL] [Abstract][Full Text] [Related]